Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVE: Varenicline for Smoking Cessation in Acute COPD Exacerbation
NCT01694732Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Aug 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in Tobacco Use Disorder (TUD), sponsored by Centre Hospitalier Universitaire de Brest. Started Aug 2012; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01694732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01694732.